Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
<p>Abstract</p> <p>Background</p> <p>Nephropathic cystinosis is an autosomal recessive disorder resulting in an impaired transport of cystine trough the lysosomal membrane causing an accumulation of free cystine in lysosomes. The only specific treatment for nephropathic...
Main Authors: | Bouazza Naïm, Tréluyer Jean-Marc, Ottolenghi Chris, Urien Saik, Deschenes Georges, Ricquier Daniel, Niaudet Patrick, Chadefaux-Vekemans Bernadette |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://www.ojrd.com/content/6/1/86 |
Similar Items
-
A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
by: Christina van Stein, et al.
Published: (2021-09-01) -
Response to Cysteamine in Osteoclasts Obtained from Patients with Nephropathic Cystinosis: A Genotype/Phenotype Correlation
by: Thomas Quinaux, et al.
Published: (2021-09-01) -
Worldwide view of nephropathic cystinosis: results from a survey from 30 countries
by: Aurélia Bertholet-Thomas, et al.
Published: (2017-07-01) -
Nephropathic cystinosis presenting with uveitis: Report of a “Can't See, Can't Pee” situation
by: Smita Mary Matthai, et al.
Published: (2019-01-01) -
Nephropathic cystinosis in children: An overlooked disease
by: Soliman Neveen, et al.
Published: (2009-01-01)